查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1593058

铁剂市场：按产品和应用分类 - 2025-2030 年全球预测

Iron Drugs Market by Product (Ferric Carboxymaltose, Iron Dextran, Iron Sucrose), Application (Cancer, Chronic Kidney Disease, Inflammatory Bowel Disease) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 186 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

根据预测，2023年铁补充剂市场价值为26.6亿美元，预计到2024年将达到28.4亿美元，复合年增长率为6.55%，到2030年将达到41.6亿美元。

铁市场包括用于治疗缺铁性贫血及相关疾病的治疗药物。这包括口服和静脉注射製剂，对于因饮食不足、消化紊乱、慢性肾臟病、怀孕或其他医疗状况而导致铁含量低的患者来说是必要的。铁製剂可满足预防和治疗需求，包括医院、诊所、家庭保健和需要透析的患者。全球贫血盛行率不断增加，增加了对有效铁补充剂治疗的需求，特别是在发展中地区。人们对贫血的认识不断提高、药物输送系统的进步以及导致缺铁的慢性疾病数量的增加正在显着影响市场的成长。奈米颗粒技术的创新和开发新型口服製剂以提高吸收率正在成为利润丰厚的机会。能够简化生产流程并提高生物有效性的公司有望获得市场占有率。然而，市场面临铁补充品的副作用、严格的监管指南以及静脉製剂的高成本等限制。挑战包括病患违规和市售补充品的竞争。儘管存在这些障碍，新兴市场仍具有创新潜力，特别是在开发铁基奈米药物和透过基因分析进行个人化治疗方法。减少口服铁製剂消化器官系统道副作用的研究以及对增加吸收和有效性且无副作用的技术的投资将提供显着的竞争优势。了解饮食性贫血盛行的新兴市场的动态，为愿意开发具有成本效益且文化适应性解决方案的公司提供了巨大的成长机会。透过优先考虑以患者为中心的创新并解决合规问题，公司可以在这个不断变化的环境中有效地定位自己。

主要市场统计
基准年[2023] 26.6亿美元
预测年份 [2024] 28.4亿美元
预测年份 [2030] 41.6亿美元
复合年增长率（%） 6.55%

市场动态：快速发展的钢铁市场的关键市场洞察

供需的动态交互作用正在改变铁补充剂市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时消费行为及其对製造成本的影响以及对采购趋势的影响。

  • 市场驱动因素
    • 铁失调和铁缺乏症的盛行率不断增加
    • 提高人们对铁补充品可用性的认识
    • 政府努力确保儿童和孕妇的铁摄取量
  • 市场限制因素
    • 造成高成本及产品召回
  • 市场机会
    • 铁製备的进展
    • 大量投资加速铁产量
  • 市场挑战
    • 与铁补充剂相关的副作用

波特五力：驾驭钢铁市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解外部对铁补充剂市场的影响

外部宏观环境因素对铁补充剂市场的表现动态起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解铁补充剂市场的竞争状况

钢铁代理市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位矩阵铁市场供应商绩效评估

FPNV定位矩阵是评估铁製剂市场供应商的重要工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议，描绘铁补充剂市场的成功之路

对于旨在加强在全球市场的影响力的公司来说，铁补充剂市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 缺铁和缺铁性疾病的盛行率增加
      • 提高人们对铁补充品可用性的认识
      • 政府努力为儿童和孕妇提供铁补充剂
    • 抑制因素
      • 高成本和产品召回
    • 机会
      • 铁製剂生产的进展
      • 大量投资加速铁产量
    • 任务
      • 与铁补充剂相关的不良反应
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章 铁市场：副产品

  • Ferric carboxymaltose
  • 聚葡萄糖铁
  • 蔗糖铁

第七章 铁剂市场：依应用分类

  • 癌症
  • 慢性肾臟病
  • 发炎性肠道疾病

第八章 北美和南美铁补充市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太地区钢铁市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章 欧洲、中东和非洲钢铁市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • AbbVie Inc.
  • Accrufer
  • Akebia Therapeutics, Inc.
  • Alembic Pharmaceuticals Limited
  • Alkem Laboratories Ltd.
  • Aqunova Pharma Private Limited
  • Astraea Life Sciences Pvt Ltd.
  • Bluebird Bio, Inc.
  • Cadila Pharmaceuticals Ltd.
  • Corona Remedies Pvt Ltd.
  • Covis Pharma GmbH
  • Dr. Reddy's Laboratories
  • Emcure Pharmaceuticals
  • Glenmark Pharmaceuticals Ltd.
  • Global Calcium Pvt.Ltd
  • GSK PLC
  • Gujarat Terce Laboratories Ltd.
  • Lupin Ltd.
  • Pfizer Inc.
  • Pharmacosmos A/S
  • Pieris Pharmaceuticals, Inc.
  • Sanofi SA
  • Solitaire Pharmacia Pvt. Ltd.
  • Sun Pharmaceutical Industries Limited
  • Takeda Pharmaceutical Company Limited
Product Code: MRR-F6513A06BEEB

The Iron Drugs Market was valued at USD 2.66 billion in 2023, expected to reach USD 2.84 billion in 2024, and is projected to grow at a CAGR of 6.55%, to USD 4.16 billion by 2030.

The iron drugs market encompasses therapeutic agents used to treat iron deficiency anemia and related conditions. These include oral and intravenous formulations, necessary for patients with low iron levels due to dietary deficiencies, gastrointestinal diseases, chronic kidney diseases, pregnancy, and other medical conditions. Iron drugs find application across hospitals, clinics, home healthcare, and for patients requiring dialysis, addressing both preventative and curative needs. As the prevalence of anemia rises globally, particularly in developing regions, there is an increasing demand for effective iron supplementation therapies. Market growth is significantly influenced by rising awareness about anemia, advancements in drug delivery systems, and an increase in chronic health conditions that lead to iron deficiencies. Innovations in nanoparticle technology and the development of novel oral formulations to improve absorption rates are emerging as lucrative opportunities. Companies that can streamline production processes and enhance bioavailability present a promising potential for capturing market share. However, the market faces limitations such as side effects associated with iron supplements, stringent regulatory guidelines, and the high cost of intravenous formulations. Challenges include patient non-compliance and competition from over-the-counter supplements. Despite these barriers, the market holds potential for innovation, particularly in the development of iron-based nanomedicines and personalized treatment options driven by genetic profiling. Investment in research to reduce the gastrointestinal side effects of oral iron products and in technology that enhances absorption and efficacy without adverse reactions will provide significant competitive advantages. Understanding the dynamics of emerging markets, where diet-related anemia is prevalent, offers substantial growth opportunities for businesses willing to develop cost-effective and culturally adaptable solutions. By prioritizing patient-centric innovations and addressing compliance issues, firms can position themselves effectively within this evolving landscape.

KEY MARKET STATISTICS
Base Year [2023] USD 2.66 billion
Estimated Year [2024] USD 2.84 billion
Forecast Year [2030] USD 4.16 billion
CAGR (%) 6.55%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Iron Drugs Market

The Iron Drugs Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rise in the prevalence of iron disorders and deficiencies
    • Growing awareness regarding the availability of iron supplements
    • Government initiatives to deliver iron drugs to children and pregnant women
  • Market Restraints
    • High cost and incidences of product recall
  • Market Opportunities
    • Advancements in manufacturing of iron drugs
    • Significant investment to accelerate iron drug manufacturing
  • Market Challenges
    • Adverse effects associated with iron drugs

Porter's Five Forces: A Strategic Tool for Navigating the Iron Drugs Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Iron Drugs Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Iron Drugs Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Iron Drugs Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Iron Drugs Market

A detailed market share analysis in the Iron Drugs Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Iron Drugs Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Iron Drugs Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Iron Drugs Market

A strategic analysis of the Iron Drugs Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Iron Drugs Market, highlighting leading vendors and their innovative profiles. These include AbbVie Inc., Accrufer, Akebia Therapeutics, Inc., Alembic Pharmaceuticals Limited, Alkem Laboratories Ltd., Aqunova Pharma Private Limited, Astraea Life Sciences Pvt Ltd., Bluebird Bio, Inc., Cadila Pharmaceuticals Ltd., Corona Remedies Pvt Ltd., Covis Pharma GmbH, Dr. Reddy's Laboratories, Emcure Pharmaceuticals, Glenmark Pharmaceuticals Ltd., Global Calcium Pvt.Ltd, GSK PLC, Gujarat Terce Laboratories Ltd., Lupin Ltd., Pfizer Inc., Pharmacosmos A/S, Pieris Pharmaceuticals, Inc., Sanofi S.A., Solitaire Pharmacia Pvt. Ltd., Sun Pharmaceutical Industries Limited, and Takeda Pharmaceutical Company Limited.

Market Segmentation & Coverage

This research report categorizes the Iron Drugs Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Ferric Carboxymaltose, Iron Dextran, and Iron Sucrose.
  • Based on Application, market is studied across Cancer, Chronic Kidney Disease, and Inflammatory Bowel Disease.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rise in the prevalence of iron disorders and deficiencies
      • 5.1.1.2. Growing awareness regarding the availability of iron supplements
      • 5.1.1.3. Government initiatives to deliver iron drugs to children and pregnant women
    • 5.1.2. Restraints
      • 5.1.2.1. High cost and incidences of product recall
    • 5.1.3. Opportunities
      • 5.1.3.1. Advancements in manufacturing of iron drugs
      • 5.1.3.2. Significant investment to accelerate iron drug manufacturing
    • 5.1.4. Challenges
      • 5.1.4.1. Adverse effects associated with iron drugs
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Iron Drugs Market, by Product

  • 6.1. Introduction
  • 6.2. Ferric Carboxymaltose
  • 6.3. Iron Dextran
  • 6.4. Iron Sucrose

7. Iron Drugs Market, by Application

  • 7.1. Introduction
  • 7.2. Cancer
  • 7.3. Chronic Kidney Disease
  • 7.4. Inflammatory Bowel Disease

8. Americas Iron Drugs Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Iron Drugs Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Iron Drugs Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. AbbVie Inc.
  • 2. Accrufer
  • 3. Akebia Therapeutics, Inc.
  • 4. Alembic Pharmaceuticals Limited
  • 5. Alkem Laboratories Ltd.
  • 6. Aqunova Pharma Private Limited
  • 7. Astraea Life Sciences Pvt Ltd.
  • 8. Bluebird Bio, Inc.
  • 9. Cadila Pharmaceuticals Ltd.
  • 10. Corona Remedies Pvt Ltd.
  • 11. Covis Pharma GmbH
  • 12. Dr. Reddy's Laboratories
  • 13. Emcure Pharmaceuticals
  • 14. Glenmark Pharmaceuticals Ltd.
  • 15. Global Calcium Pvt.Ltd
  • 16. GSK PLC
  • 17. Gujarat Terce Laboratories Ltd.
  • 18. Lupin Ltd.
  • 19. Pfizer Inc.
  • 20. Pharmacosmos A/S
  • 21. Pieris Pharmaceuticals, Inc.
  • 22. Sanofi S.A.
  • 23. Solitaire Pharmacia Pvt. Ltd.
  • 24. Sun Pharmaceutical Industries Limited
  • 25. Takeda Pharmaceutical Company Limited

LIST OF FIGURES

  • FIGURE 1. IRON DRUGS MARKET RESEARCH PROCESS
  • FIGURE 2. IRON DRUGS MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL IRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL IRON DRUGS MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL IRON DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL IRON DRUGS MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL IRON DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL IRON DRUGS MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES IRON DRUGS MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES IRON DRUGS MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. IRON DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. IRON DRUGS MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. IRON DRUGS MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL IRON DRUGS MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL IRON DRUGS MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. IRON DRUGS MARKET DYNAMICS
  • TABLE 7. GLOBAL IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL IRON DRUGS MARKET SIZE, BY FERRIC CARBOXYMALTOSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL IRON DRUGS MARKET SIZE, BY IRON DEXTRAN, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL IRON DRUGS MARKET SIZE, BY IRON SUCROSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL IRON DRUGS MARKET SIZE, BY CANCER, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL IRON DRUGS MARKET SIZE, BY CHRONIC KIDNEY DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL IRON DRUGS MARKET SIZE, BY INFLAMMATORY BOWEL DISEASE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. AMERICAS IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 16. AMERICAS IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 18. ARGENTINA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 19. ARGENTINA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. BRAZIL IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 21. BRAZIL IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. CANADA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 23. CANADA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. MEXICO IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 25. MEXICO IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. UNITED STATES IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 27. UNITED STATES IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES IRON DRUGS MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 29. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 30. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 32. AUSTRALIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. AUSTRALIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. CHINA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 35. CHINA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. INDIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. INDIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDONESIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 39. INDONESIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. JAPAN IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. JAPAN IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. MALAYSIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 43. MALAYSIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. PHILIPPINES IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. PHILIPPINES IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. SINGAPORE IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 47. SINGAPORE IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SOUTH KOREA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 49. SOUTH KOREA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. TAIWAN IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 51. TAIWAN IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. THAILAND IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 53. THAILAND IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. VIETNAM IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. VIETNAM IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 57. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA IRON DRUGS MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 59. DENMARK IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 60. DENMARK IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. EGYPT IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 62. EGYPT IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. FINLAND IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 64. FINLAND IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FRANCE IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 66. FRANCE IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. GERMANY IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 68. GERMANY IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. ISRAEL IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 70. ISRAEL IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ITALY IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 72. ITALY IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NETHERLANDS IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 74. NETHERLANDS IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NIGERIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 76. NIGERIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NORWAY IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 78. NORWAY IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. POLAND IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 80. POLAND IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. QATAR IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 82. QATAR IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. RUSSIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 84. RUSSIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SAUDI ARABIA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 86. SAUDI ARABIA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH AFRICA IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH AFRICA IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SPAIN IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 90. SPAIN IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SWEDEN IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 92. SWEDEN IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWITZERLAND IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 94. SWITZERLAND IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. TURKEY IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 96. TURKEY IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. UNITED ARAB EMIRATES IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 98. UNITED ARAB EMIRATES IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED KINGDOM IRON DRUGS MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED KINGDOM IRON DRUGS MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. IRON DRUGS MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 102. IRON DRUGS MARKET, FPNV POSITIONING MATRIX, 2023